ALX Oncology Reports Durable HER2 Breast Cancer Data
SOUTH SAN FRANCISCO, Calif., May 7, 2026 ALX Oncology announced promising new clinical findings showing that its investigational CD47...
Vaccines, Blood & Biologics
TRexBio Reports New TRB-061 Data for Atopic Dermatitis
SOUTH SAN FRANCISCO, Calif., May 7, 2026 TRexBio announced new late-breaking translational and preclinical data supporting TNFR2 agonism as...
Beacon Therapeutics Reports Positive XLRP Gene Therapy Data
LONDON and CAMBRIDGE, Mass., May 7, 2026 Beacon Therapeutics announced encouraging 12-month safety and efficacy results from its ongoing...
Pierre Fabre Advances FDA Path for Tabelecleucel
SECAUCUS, N.J., May 7, 2026 Pierre Fabre Pharmaceuticals (PFP) announced a significant regulatory update following a Type A meeting...
GSK Signs $1B SiranBio siRNA Cardiometabolic Deal
SUZHOU, China, May 6, 2026 SiranBio announced a major global licensing agreement with GSK for its investigational siRNA therapeutic...
Waiv and Daiichi Sankyo Partner on AI Biomarkers
PARIS, France, May 8, 2026 Waiv, the Paris-based artificial intelligence precision medicine company formerly known as Owkin Dx, announced...
Edgewise Advances Muscle and Heart Disease Pipeline
BOULDER, Colo., May 7, 2026 Edgewise Therapeutics reported first quarter 2026 financial results while highlighting major progress across its...
Revolution Medicines Publishes Daraxonrasib Pancreatic Cancer Data in NEJM
Redwood City, Calif., May 6, 2026 Revolution Medicines, Inc. announced the publication of important Phase 1/2 clinical trial data...
Aurion Biotech Highlights AURN001 Cell Therapy at ASGCT 2026
Seattle, WA; Cambridge, MA; Tokyo, Japan – May 6, 2026 Aurion Biotech, Inc. announced that it will deliver an...
Ribo and Boehringer Advance siRNA MASH Program
SUZHOU, China, May 6, 2026 Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB announced the achievement of...